LOEWI

Exit

LOEWI GmbH is a scientific spin-off of the TU München with the mission to make personalized health and nutrition available to everyone by combining science and technology. LOEWI's patented personalization concept analyzes health relevant data of customers and patients, makes the analysis available via LOEWI's Health Profile (Medical Software Class I), and creates personalized nutrient recommendations and therapies using a sophisticated recommendation algorithm, which are 100% tailored to the personal needs of each customer and patient.

Press releases

Press
26. January 2022

UK-based health tech company bioniq acquires LOEWI

LOEWI is a scientific spin-off of the TU München, which provides tailor-made nutrients based on your blood work and lifestyleThe acquisition is a continuation of bioniq´s global expansion and accelerates the European market presenceHigh-Tech Gründerfonds invested in LOEWI´s seed round in 2020   London, January 26th – Through the acquisition to the UK-based health tech company bioniq, High-Tech Gründerfonds (HTGF) has sold its stake in LOEWI, a scientific spin-off of the TU
 
Press
17. June 2020

LOEWI GmbH receives seed financing to make personalized health and nutrition available for everyone

The Munich-based technology company LOEWI has received new capital from High-Tech Gründerfonds (HTGF) and a German family office in a seed financing round. The scientific spin-off of the Technical University of Munich is one of the technology leaders in the field of personalized nutrition and health and has been mainly active in competitive sports so far. Among LOEWI´s clients are teams and clubs from Tour de France and UEFA Europa League. The investment is an important step to push the
 

Info & Contact

Phone:
+49 89 23792242
Web:
loewi.com

Address

Agnes-Pockels-Bogen 1
80992 München
Deutschland

In portfolio

04. Feb 2020 – 26. Jan 2022

HTGF Manager

 
Niels Sharman, Investment Manager
Exit